François Gueyffier

9.8k total citations · 1 hit paper
147 papers, 6.6k citations indexed

About

François Gueyffier is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Economics and Econometrics. According to data from OpenAlex, François Gueyffier has authored 147 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Cardiology and Cardiovascular Medicine, 26 papers in Endocrinology, Diabetes and Metabolism and 26 papers in Economics and Econometrics. Recurrent topics in François Gueyffier's work include Blood Pressure and Hypertension Studies (38 papers), Health Systems, Economic Evaluations, Quality of Life (26 papers) and Statistical Methods in Clinical Trials (14 papers). François Gueyffier is often cited by papers focused on Blood Pressure and Hypertension Studies (38 papers), Health Systems, Economic Evaluations, Quality of Life (26 papers) and Statistical Methods in Clinical Trials (14 papers). François Gueyffier collaborates with scholars based in France, United States and United Kingdom. François Gueyffier's co-authors include Robert Fagard, Jan A. Staessen, Stuart Pocock, Karla Kerlikowske, Florent Boutitie, John Coope, Jean‐Pierre Boissel, Michel Cucherat, Lutgarde Thijs and Eleanor Schron and has published in prestigious journals such as The Lancet, Circulation and Nature Communications.

In The Last Decade

François Gueyffier

143 papers receiving 6.3k citations

Hit Papers

Risks of untreated and treated isolated systolic hyperten... 2000 2026 2008 2017 2000 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials
    2000 794 citations Jean‐Pierre Boissel, François Gueyffier et al. profile →

Peers

François Gueyffier
Connor A. Emdin United Kingdom
Simon Anderson United Kingdom
Maciej Tomaszewski United Kingdom
Martin Landray United Kingdom
Mark Brown Australia
Michael Griswold United States
Robert C. Kaplan United States
Emir Veledar United States
Roger Holder United Kingdom
Mary Pettinger United States
Connor A. Emdin United Kingdom
François Gueyffier
Citations per year, relative to François Gueyffier François Gueyffier (= 1×) peers Connor A. Emdin

Countries citing papers authored by François Gueyffier

Since Specialization
Citations

This map shows the geographic impact of François Gueyffier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Gueyffier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Gueyffier more than expected).

Fields of papers citing papers by François Gueyffier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Gueyffier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Gueyffier. The network helps show where François Gueyffier may publish in the future.

Co-authorship network of co-authors of François Gueyffier

This figure shows the co-authorship network connecting the top 25 collaborators of François Gueyffier. A scholar is included among the top collaborators of François Gueyffier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Gueyffier. François Gueyffier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Merenciano, Miriam, Marie Fablet, Anamaria Necşulea, et al.. (2025). Transposable element expression is associated with sex chromosome number in humans. PLoS Genetics. 21(6). e1011668–e1011668. 1 indexed citations
3.
Gougeon, A., Jean‐Christophe Lega, James M Wright, et al.. (2024). Publication bias in pharmacogenetics of statin-associated muscle symptoms: A meta-epidemiological study. Atherosclerosis. 400. 118624–118624. 3 indexed citations
4.
Gueyffier, François & Rémy Boussageon. (2024). Fondamentaux de l’évaluation des thérapeutiques, médicamenteuses et non médicamenteuses – un cadre pour l’évaluation des processus d’autoguérison. HEGEL - HEpato-GastroEntérologie Libérale. N° 4(4). 347–358.
5.
6.
Browning, Barbara, Françoise Couenne, Claire Bordes, et al.. (2020). Dynamical modeling of pro- and anti-inflammatory cytokines in the early stage of septic shock. In Silico Biology. 13(3-4). 101–121. 4 indexed citations
7.
Laviolle, Bruno, Olivier Perche, François Gueyffier, et al.. (2018). Apport de la génomique dans la médecine de demain, applications cliniques et enjeux. Therapies. 74(1). 1–8. 1 indexed citations
8.
Al‐Gobari, Muaamar, Sinaa Al-Aqeel, François Gueyffier, & Bernard Burnand. (2018). Effectiveness of drug interventions to prevent sudden cardiac death in patients with heart failure and reduced ejection fraction: an overview of systematic reviews. BMJ Open. 8(7). e021108–e021108. 32 indexed citations
9.
Laviolle, Bruno, Patrice Denèfle, François Gueyffier, et al.. (2018). The contribution of genomics in the medicine of tomorrow, clinical applications and issues. Therapies. 74(1). 9–15. 3 indexed citations
10.
Gueyffier, François, Pascal Piedbois, Jean‐François Bergmann, et al.. (2017). How to measure the net benefit of treatment?. Therapies. 72(1). 51–61. 2 indexed citations
11.
Grenet, Guillaume, et al.. (2016). Protocol of GLUcose COntrol Safety and Efficacy in type 2 DIabetes, a NETwork meta‐analysis: GLUCOSE DINET protocol—Rational and design. Fundamental and Clinical Pharmacology. 31(3). 258–264. 4 indexed citations
12.
Dobre, Daniela, Jeffrey Borer, Keith A.A. Fox, et al.. (2013). Heart Rate: A Prognostic Factor and Therapeutic Target in Chronic Heart Failure. The distinct Roles of Drugs with Heart Rate-Lowering Properties. European Journal of Heart Failure. 16(1). 76–85. 65 indexed citations
13.
14.
Tod, Michel, et al.. (2013). Quantitative Prediction of the Impact of Drug Interactions and Genetic Polymorphisms on Cytochrome P450 2C9 Substrate Exposure. Clinical Pharmacokinetics. 52(3). 199–209. 30 indexed citations
15.
Scholtès, Caroline, Patrice André, Christian Trépo, et al.. (2012). Farnesoid X Receptor Targeting for Hepatitis C: Study Protocol for a Proof-of-concept Trial. Therapies. 67(5). 423–427. 3 indexed citations
16.
Marchant, Ivanny, Patrice Nony, Michel Cucherat, et al.. (2011). The Global Risk Approach Should Be Better Applied in French Hypertensive Patients: A Comparison between Simulation and Observation Studies. PLoS ONE. 6(3). e17508–e17508. 13 indexed citations
17.
Boussageon, Rémy, et al.. (2008). Critique du modèle additif de l’essai clinique randomisé. Therapies. 63(1). 29–35. 3 indexed citations
18.
Paris, Adeline, et al.. (2005). Lisibilité de l’information écrite destinée aux sujets se prêtant à une recherche biomédicale. La Presse Médicale. 34(1). 13–18. 11 indexed citations
19.
Boissel, Jean‐Pierre, et al.. (2003). How should therapeutic information be transferred to users?. Fundamental and Clinical Pharmacology. 17(4). 495–503. 4 indexed citations
20.
Lièvre, Michel, François Gueyffier, Tord Ekbom, et al.. (2000). Efficacy of diuretics and beta-blockers in diabetic hypertensive patients. Results from a meta-analysis. Diabetes Care. 23. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Connor A. Emdin Breakdown of academic impact, for papers by Simon Anderson Breakdown of academic impact, for papers by Maciej Tomaszewski Breakdown of academic impact, for papers by Martin Landray Breakdown of academic impact, for papers by Mark Brown Breakdown of academic impact, for papers by Michael Griswold Breakdown of academic impact, for papers by Robert C. Kaplan Breakdown of academic impact, for papers by Emir Veledar Breakdown of academic impact, for papers by Roger Holder Breakdown of academic impact, for papers by Mary Pettinger
Rankless by CCL
2026